![HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients | The Journal of Immunology HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/185/12/7452/F1.large.jpg)
HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients | The Journal of Immunology
The Pathophysiological Impact of HLA Class Ia and HLA-G Expression and Regulatory T Cells in Malignant Melanoma: A Review
![HLA-E expression in diffuse glioma: relationship with clinicopathological features and patient survival | BMC Neurology | Full Text HLA-E expression in diffuse glioma: relationship with clinicopathological features and patient survival | BMC Neurology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12883-020-01640-4/MediaObjects/12883_2020_1640_Fig3_HTML.png)
HLA-E expression in diffuse glioma: relationship with clinicopathological features and patient survival | BMC Neurology | Full Text
![HLA-E expression in diffuse glioma: relationship with clinicopathological features and patient survival | BMC Neurology | Full Text HLA-E expression in diffuse glioma: relationship with clinicopathological features and patient survival | BMC Neurology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12883-020-01640-4/MediaObjects/12883_2020_1640_Fig1_HTML.png)
HLA-E expression in diffuse glioma: relationship with clinicopathological features and patient survival | BMC Neurology | Full Text
![Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer - ScienceDirect Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0198885919313308-gr3.jpg)
Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer - ScienceDirect
![HLA-E expression in diffuse glioma: relationship with clinicopathological features and patient survival | BMC Neurology | Full Text HLA-E expression in diffuse glioma: relationship with clinicopathological features and patient survival | BMC Neurology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12883-020-01640-4/MediaObjects/12883_2020_1640_Fig2_HTML.png)
HLA-E expression in diffuse glioma: relationship with clinicopathological features and patient survival | BMC Neurology | Full Text
![The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment - ScienceDirect The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804917312893-gr2.jpg)
The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment - ScienceDirect
![The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment - ScienceDirect The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804917312893-gr3.jpg)
The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment - ScienceDirect
![HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients | The Journal of Immunology HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/185/12/7452/F3.large.jpg)
HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients | The Journal of Immunology
![HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells | Nature Biotechnology HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells | Nature Biotechnology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnbt.3860/MediaObjects/41587_2017_Article_BFnbt3860_Fig1_HTML.jpg)
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells | Nature Biotechnology
![HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients | The Journal of Immunology HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/185/12/7452/F2.large.jpg)
HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients | The Journal of Immunology
![Human leukocyte antigen‑G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment (Review) Human leukocyte antigen‑G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment (Review)](https://www.spandidos-publications.com/article_images/ol/15/1/ol-15-01-0699-g00.jpg)
Human leukocyte antigen‑G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment (Review)
![Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses | Cancer Immunology Research Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses | Cancer Immunology Research](https://cancerimmunolres.aacrjournals.org/content/canimm/7/8/1293/F6.large.jpg)